Hemay005 not checked

Ganzhou Hemay Pharmaceutical Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
9 active
23 in total · 6 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants receive treatment with Hemay005 tablet during the Maintenance Phase (week M-0\~M-40).”In the company’s words, NCT07650942 on ClinicalTrials.gov
Tested for
Behçet's Disease, Ulcerative Colitis (UC), Moderate to Severe Ulcerative Colitis, COPD (Chronic Obstructive Pulmonary Disease), Psoriasis
Main trialPhase 3
“This is a phase 3, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and placebo treatment groups. After subject randomization, each subject will enter an core-treatment Phase for 12 weeks following an extended-treatment phase for another 40 weeks and a follow up phase for 4weeks.”In the company’s words, NCT06145893 on ClinicalTrials.gov
Other names
Mufemilast · No other intervention name.

Other drugs for Behçet's Disease

All 3 drugs for Behçet's Disease

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials23

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 May 2026 A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
Phase 3Not yet recruiting May 2028 Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Phase 2Active, not recruiting 30 Dec 2026 Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
Phase 2Not yet recruiting 31 Dec 2027 A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD
Phase 1Recruiting 10 Dec 2025 To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Phase 3Completed 25 Oct 2022 A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
Phase 2Completed 12 Oct 2020 Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
Phase 2Terminated 30 Apr 2022 A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
Phase 2Completed 18 Aug 2023 Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
Phase 2Completed 24 Jan 2024 A Study of Hemay005 in Adult With Atopic Dermatitis
Phase 1Completed 1 Aug 2021 Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
Phase 1Completed 1 Sep 2022 In Vivo Mass Balance Study of [14C]Hemay005
Phase 1Completed 8 Aug 2023 A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers
Phase 1Completed 30 Sep 2024 Bioequivalence Test of Hemay005 Tablets
Phase 1Completed 20 Jan 2025 Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
Phase 1Completed 16 Apr 2025 To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
Phase 1Completed 3 Jun 2025 Evaluation the Safety of hemay005 Tablets
Phase 3Authorised not given A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Phase 3Authorised not given A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure
Phase 3/4Ended not given The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation
Phase 2Not authorised not given A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE
Phase 2Authorised not given Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial
Phase 3Authorised not given Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Hemay005

Following is part of Solo: you see every change to Hemay005 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in